The majority of patients with cystic fibrosis (CF) will grow into adulthood. Despite this improvement in survival, the disease is progressive, especially with respect to the decline in pulmonary function, which in turn may have an impact on a patient's quality of life. In this study we evaluated the
Role of progestational agents in the treatment of undernourished patients with cystic fibrosis
β Scribed by Dana G. Kissner
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 52 KB
- Volume
- 29
- Category
- Article
- ISSN
- 8755-6863
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Four patients with severe cystic fibrosis lung disease, anorexia and weight loss, received Megestrol Acetate (MA), as an appetite stimulant. The initial dose was 400-800 mg daily and was continued for 6-15 months. Appetite was improved, with significant weight gain in all patients and an increase in
The suggested incidence of cystic fibrosis (CF) in Asian migrants (Indians and Pakistanis) in the United Kingdom is about 1 in 10,000 to 12,000 [Goodchild et al., 1974]. There are no large studies on CF in Asian Indians. The disorder is thought to be rare and most studies from the Asian subcontinent
We report survival data for Danish center-treated cystic fibrosis (CF) patients, covering the period 1974-1 993 and using cross-sectional cumulative survival probability based on annual age-specific mortality rates. Analyses by age and by years after diagnosis were made. No significant differences w